Molecular epidemiology of HIV-1 subtypes and drug resistant strains in Taiwan

Journal of Medical Virology

Volumn 80, Issue 2, 2008, Pages 183-191

  Lan, Yu Ching ^a,b   Elbeik, Tarek ^c,d   Dileanis, JoAnn ^e   Ng, Valerie ^c,d   Chen, Yen Ju ^a   Leu, Hsieh Shong ^f   Cheng, Shu Hsing ^g   Wong, Jen Chien ^h   Wong, Wing Wai ^a,i   Chen, Yi Ming A ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

^e CELERA   (United States)

^f CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^g TAO YUAN GENERAL HOSPITAL   (Taiwan)

^h CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

ⁱ TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

HIV drug resistance; HIV subtype; Molecular epidemiology

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COMPLEMENTARY DNA; DEOXYCYTIDINE; DIDANOSINE; RNA; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BISEXUALITY; BLOOD SAMPLING; BLOOD TRANSFUSION; DNA SEQUENCE; EPIDEMIC; FEMALE; HEMOPHILIA; HETEROSEXUALITY; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PHYLOGENY; PROSTITUTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIWAN; VIRUS MUTATION; VIRUS RECOMBINANT; VIRUS TRANSMISSION; VIRUS TYPING;

AMINO ACID SUBSTITUTION; DRUG RESISTANCE, VIRAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MALE; MUTATION, MISSENSE; PHYLOGENY; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; TAIWAN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 37548999033     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21065     Document Type: Article

References (32)

1. Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, Tsay J, Ip J, Farthing C, Limoli K, Parkin N, Markowitz M. 1999. HIV-1 drug resistance in newly infected individuals. JAMA 282:1135-1141.
2. Chang SY, Sheng WH, Lee CN, Sun HY, Kao CL, Chang SF, Liu WC, Yang JY, Wong WW, Hung CC, Chang SC. 2006. Molecular epidemiology of HIV Type 1 subtypes in Taiwan: Outbreak of HIV type 1 CRF07_BC infection in Intravenous Drug Users 2006. AIDS Res Hum Retroviruses 22:1055-1066.
3. Center for Disease Control Taiwan. 2002. 2002 Mortality data of Infectious Disease. [Online in Chinese]. http://www.doh.gov.tw/lane/statist/ 910315/910313-7.htm
4. Chen YM, Huang KL, Jen I, Chen SC, Liu YC, Chuang YC, Wong JC, Tsai JJ, Lan YC. 2001. Temporal trends and molecular epidemiology of HIV-1 infection in Taiwan from 1988 to 1998. J Acquir Immune Defic Syndr 26:274-282.
5. Chen YM, Lee CM, Lin RY, Chang HJ. 1998. Molecular epidemiology and trends of HIV-1 subtypes in Taiwan. J Acquir Immune Defic Syndr Hum Retroviral 19:393-402.
6. Chen YM, Lan YC, Lai SF, Yang JY, Tsai SF, Kuo HS. 2006. HIV-1 CRF07_BC infections, injecting drug users, Taiwan. Emerg Infect Dis 12:703-705.
7. Chen YM, Kuo HS. 2007. HIV-1 in Taiwan. Lancet 369:623-625.
8. Elbeik T, Chun TW, Imamichi H, Natarajan V, Waters D, Dewar RL, Highbarger H. 2002. Quantitation of viremia and determination of drug resistance in patients with human immunodeficiency virus infection. In: Rose NR, Hamilton RG, Detrick B, editors. Manual of Clinical Laboratory Immunology. 6th edition. Washington DC: American Society for Microbiology. pp 772-789.
9. Fang CT, Hsu HM, Twu SJ, Chen MY, Chang YY, Hwang JS, Wang JD, Chuang CY. 2004. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis 190:879-885.
10. HIV Drug Resistance Program, WHO and CDC. 2004. International HIV drug resistance threshold survey to monitor transmission of HIV drug resistant strains in resource-limited settings. http://www.phppo.cdc.gov/dls/ila/cd/ HIVSurveillance/presentations/ group3.pps
11. Lin YT, Lan YC, Chen YJ, Liu TT, Yang JY, Wong WW, Wang CT, Chen YM. 2007. Molecular epidemiology and full-length genomic analysis of HIV-1 circulating recombinant form 07_BC strains from injecting drug users in Taiwan. J Infect Dis 195:1283-1293.
12. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, Hahn BH, Wolinsky S, Bhattacharya T. 2000. Timing the ancestor of the HIV-1 pandemic strains. Science 288:1789-1796.
13. Lemey P, Pybus OG, Wang B, Saksena NK, Salemi M, Vandamme AM. 2003. Tracing the origin and history of the HIV-2 epidemic. PNAS 100:6588-6592.
14. Lim WL, Xing H, Wong KH, Wong MC, Shao YM, Ng MH, Lee SS. 2004. The lack of epidemiological link between the HIV type 1 infections in Hong Kong and Mainland China. AIDS Res Hum Retroviruses 20:259-262.
15. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD. 2002. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 347:385-394.
16. Los Alamos National Laboratory. 2004. 2004 HIV Sequence Database. [Online], http://www.hiv.lanl.gov/content/index
17. McClutchan FE, Carr JK, Murphy D, Piyasirisilp S, Gao F, Hahn B, Yu XF, Beyrer C, Birx DL. 2002. Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China. AIDS Res Hum Retroviruses 18:1135-1140.
18. McCutchan FE. 2000. Understanding the genetic diversity of HIV-1. AIDS 14:S31-S44.
19. Ou CY, Ciesielski CA, Myers GF, Bandea CI, Luo CC, Korber BT, Mullins JI, Schochetman GF, Berkelman RL, Economou AN. 1992. Molecular epidemiology of HIV transmission in a dental practice. Science 256:1165-1171.
20. Perez-Olmeda M, Del RJ, Rubio A, Ruiz L, Rodriguez C, Leal M, Clotet B, Soriano V. 2001. Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors. J Med Virol 63:85-87.
21. Piyasirisilp S, McCutchan FE, Carr JK, Sanders-Buell E, Liu W, Chen J, Wagner R, Wolf H, Shao Y, Lai S, Beyrer C, Yu XF. 2000. A recent outbreak of human immunodeficiency virus Type 1 Infection in Southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 74:11286-11295.
22. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp PM, Wolinsky S, Korber B. 2000. HIV-1 nomenclature proposal. Science 288:55-56.
23. Ruan YJ, Wei CL, Ling AE, Vega VB, Thoreau H, Se Thoe SY, Chia JM, Ng P, Chiu KP, Lim L. 2003. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 361:1779-1785.
24. Su L, Graf M, Zhang Y, von Briesen H, Xing H, Kostler J, Melzl H, Wolf H, Shao Y, Wagner R. 2000. Characterization of a virtually full-length human immunodeficiency virus Type 1 genome of a prevalent intersubtype (C/B′) recombinant strain in China. J Virol 74:11367-11376.
25. Sun HY, Chen MJ, Hung CC, Chen MY, Hsieh SM, Sheng WH, Fang CT, Chang SY, Chang SC. 2004. Clinical presentations and virologic characteristics of primary human immunodeficiency virus type-1 infection in a university hospital in Taiwan. J Microbiol Immunol Infect 37:271-275.
26. Takebe Y, Kusagawa S, Motomura K. 2004. Molecular epidemiology of HIV: Tracking AIDS pandemic. Pediatr Int 46:236-244.
27. Travers SAA, Clewley JP, Glynn JR, Fine PEM, Crampin AC, Sibande F, Mulawa D, McInerney JO, McCormack GP. 2004. Timing and reconstruction of the most recent common ancestor of the subtype C clade of human immunodeficiency virus Type 1. J Virol 78:10501-10506.
28. UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance. 2001. Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. BMJ 322:1087-1088.
29. Yang R, Xia X, Kusagawa S, Zhang C, Ben K, Takebe Y. 2002. On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China. AIDS 16:1401-1407.
30. Yang R, Kusagawa S, Zhang C, Xia X, Ben K, Takebe Y. 2003. Identification and characterization of a new class of human immunodeficiency virus Type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China. J Virol 77:685-695.
31. Zhang L, Chen Z, Cao Y, Yu J, Li G, Yu W, Yin N, Mei S, Li L, Balfe P, He T, Ba L, Zhang F, Lin HH, Yuen MF, Lai CL, Ho DD. 2004. Molecular characterization of human immunodeficiency virus Type 1 and hepatitis C virus in paid blood donors and injection drug users in China. J Virol 78:13591-13599.
32. Zhong P, Kang L, Pan Q, Konings F, Burda S, Ma L, Xue Y, Zheng X, Jin Z, Nyambi P. 2003. Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P.R. China. J Acquir Immune Defic Syndr 34:91-101.